How M.D. was paid
$6.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Total |
|---|---|---|---|---|
| Tien-Li Lee, M.D.Chief Executive Officer | $630,788 | $5,093,026 | $342,870 | $6,066,684 |
| Nelson SunChief Financial Officer and Chief Operating Officer | $432,654 | $1,944,646 | $170,646 | $2,547,946 |
| Manasi Jaiman, M.D., M.P.H.Chief Medical Officer | $495,962 | $1,177,014 | $197,077 | $1,870,053 |
What changed and why
- $6.1M$6.1M was CEO total compensation in 2025, up from $906,322 in 2024, primarily reflecting higher option awards.
- 100%100% of 2025 corporate goals were achieved, resulting in named executives receiving bonuses at their respective target levels.
- $5.1M$5.1M was CEO option-award grant-date fair value in 2025, compared with $203,223 in 2024.
- 55%55% became the CEO’s annual target bonus percentage after the IPO, up from 40% previously.
- $11.29$11.29 was the exercise price for the June 2025 option grants, which vest monthly over 48 months.
- The Severance Plan provides 12 months of salary, target bonus, benefits, and accelerated equity vesting after qualifying change-in-control terminations.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.